Alessio Alionço is the founder and CEO of Pipefy, a global leader in AI-driven low code business process automation solutions. Today’s modern factories are sleek, precise and functional. This is ...
The manufacturing industry operates in a high-stakes environment where standing still is the same as falling behind. Rapid advancements in technology, evolving customer expectations, and intense ...
For many decades, businesses have focused their manufacturing operations in faraway production locations where labor and shipping costs are traditionally more affordable. However, recent global ...
Process manufacturing is extremely complex. Operating in a manner that ensures safety, reliability, efficiency and sustainability requires precise orchestration of equipment, people and data to ensure ...
Composites, once confined to aerospace and automotive sectors, are now driving innovation across freight, construction and energy industries, enhancing sustainability and competitiveness. CAMX 2024 ...
Terms can sometimes play tricks on the mind. Take EtherNet/IP, for example. Many people will read “IP” as internet protocol and think that EtherNet/IP refers to plain old, standard industrial Ethernet ...
A novel approach to automating cell therapy manufacturing using industry-standard equipment can potentially reduce human errors, deliver higher quality product, and lower manufacturing costs by ...
Gain knowledge and strategies for optimizing plant safety and efficiency. These training courses include topics such as alarm management, SCADA systems, P&ID loop, batch control, HMI, fire and gas ...
HUNTSVILLE, Ala.--(BUSINESS WIRE)--Aerobotix and Manufacturing Automation Systems (MAS), two leading FANUC robot integrators, today announced they will demonstrate intelligent adaptive sanding at ...
In this article, we take a look at 10 Best Industrial Automation Stocks to Buy Now. Industrial automation is moving from ...
Defining the steps involved in a successful technology transfer process would benefit biopharma, say the researchers behind a “generic” blueprint intended to help drug makers move more easily from ...